Small peptide CSF fingerprint of amyotrophic lateral sclerosis
PLOS ONE · 2024
DOI: 10.1371/journal.pone.0302280 ↗Kurz gefasst
Fachartikel in der Zeitschrift PLOS ONE, 2024. Verfasst von Rea Lumi und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, Hannover University Medical School, Hannover, Germany. Hauptthemen laut MEDLINE: Amyotrophic Lateral Sclerosis, Peptides. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 49 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Amyotrophic lateral sclerosis (ALS) is a neurodegenerative disease characterized by abnormal protein aggregation in the motor neurons. Present and earlier proteomic studies to characterize peptides in cerebrospinal fluid (CSF) associated with motoneuron pathology did not target low molecular weight proteins and peptides. We hypothesized that specific changes in CSF peptides or low molecular weight proteins are significantly altered in ALS, and that these changes may support deciphering molecular pathophysiology and even guide approaches towards therapeutic interventions.
Methods
Cerebrospinal fluid (CSF) from 50 ALS patients and 50 non-ALS controls was collected, centrifuged immediately after collection, aliquoted into polypropylene test tubes, frozen within 30–40 min after the puncture, and stored at −80°C until use. Peptides were sequenced using capillary electrophoresis or liquid chromatography/mass spectrometry (CE-MS/MS or LC-MS/MS).
Findings
In the CSF of 50 patients and 50 non-ALS controls 33 peptides were found, of which 14 could be sequenced using a non-lytic single-pot proteomic detection method, CE/MS. ALS deregulated peptides vs. controls included Integral membrane protein 2B, Neurosecretory protein VGF, Osteopontin, Neuroendocrine protein 7B2 (Secretogranin-V), EGF-containing fibulin-like extracellular matrix protein 1, Xylosyltransferase 1 XT-1, Chromogranin-A, Superoxide dismutase SOD-1, Secretogranin-1 (Chromogranin B), NR2F2 Nuclear Receptor Subfamily 2 Group F Member 2 and Collagen alpha-1(VII) chain.
Interpretation
Most striking deregulations in CSF from ALS patients were found in VGF, Osteopontin, SOD-1 and EFEMP1 peptides. No associations of disease severity, duration and region of onset with sequenced peptides were found.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Neurology, Hannover University Medical School, Hannover, Germany.
- Mosaiques Diagnostics GmbH, Hannover, Germany.
- Kuratorium for Dialysis and Kidney Transplantation, Neu-Isenburg, Germany.
- Martin-Luther-University Halle/Wittenberg, Halle/Saale, Germany.
- Hospital Sankt Georg gGmbH, Leipzig, Germany.
ORCID-Profile: Justyna Siwy, Agnieszka Latosinska, Joachim Beige
Zitieren
APA
Lumi, R., Petri, S., Siwy, J., Latosinska, A., Raad, J., Zürbig, P., Skripuletz, T., Mischak, H., & Beige, J. (2024). Small peptide CSF fingerprint of amyotrophic lateral sclerosis. PLOS ONE. https://doi.org/10.1371/journal.pone.0302280
Vancouver
Lumi R, Petri S, Siwy J, Latosinska A, Raad J, Zürbig P, et al. Small peptide CSF fingerprint of amyotrophic lateral sclerosis. PLOS ONE. 2024. doi:10.1371/journal.pone.0302280
BibTeX
@article{Lumi2024,
author = {Lumi, Rea and Petri, Susanne and Siwy, Justyna and Latosinska, Agnieszka and Raad, Julia and Zürbig, Petra and Skripuletz, Thomas and Mischak, Harald and Beige, Joachim},
title = {Small peptide CSF fingerprint of amyotrophic lateral sclerosis},
journal = {PLOS ONE},
year = {2024},
doi = {10.1371/journal.pone.0302280}
}
EUVIMED